Peripheral vascular reactivity and serum BDNF responses to aerobic training are impaired by the BDNF Val66Met polymorphism
Carregando...
Citações na Scopus
32
Tipo de produção
article
Data de publicação
2016
Editora
AMER PHYSIOLOGICAL SOC
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
ALVES, Cleber R.
TEIXEIRA, Antnio L.
VIEIRA, Erica L. M.
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
PHYSIOLOGICAL GENOMICS, v.48, n.2, p.116-123, 2016
Resumo
Besides neuronal plasticity, the neurotrophin brain-derived neurotrophic factor (BDNF) is also important in vascular function. The BDNF has been associated with angiogenesis through its specific receptor tropomyosin-related kinase B (TrkB). Additionally, Val66Met polymorphism decreases activity-induced BDNF. Since BDNF and TrkB are expressed in vascular endothelial cells and aerobic exercise training can increase serum BDNF, this study aimed to test the hypotheses: 1) Serum BDNF levels modulate peripheral blood flow; 2) The Val66Met BDNF polymorphism impairs exercise training-induced vasodilation. We genotyped 304 healthy male volunteers (Val66Val, n = 221; Val66Met, n = 83) who underwent intense aerobic exercise training on a running track three times/wk for 4 mo. We evaluated pre- and post-exercise training serum BDNF and proBDNF concentration, heart rate (HR), mean blood pressure (MBP), forearm blood flow (FBF), and forearm vascular resistance (FVR). In the pre-exercise training, BDNF, proBDNF, BDNF/proBDNF ratio, FBF, and FVR were similar between genotypes. After exercise training, functional capacity ((v)over dot(O2) (peak)) increased and HR decreased similarly in both groups. Val66Val, but not Val66Met, increased BDNF (interaction, P = 0.04) and BDNF/proBDNF ratio (interaction, P < 0.001). Interestingly, FBF (interaction, P = 0.04) and the FVR (interaction, P = 0.01) responses during handgrip exercise (HG) improved in Val66Val compared with Val66Met, even with similar responses of HR and MBP. There were association between BDNF/proBDNF ratio and FBF (r = 0.64, P < 0.001) and FVR (r = -0.58,P < 0.001) during HG exercise. These results show that peripheral vascular reactivity and serum BDNF responses to exercise training are impaired by the BDNF Val66Met polymorphism and such responsiveness is associated with serum BDNF concentrations in healthy subjects.
Palavras-chave
BDNF Val66Met polymorphism, exercise training, vascular reactivity
Referências
- Mortensen SP, 2009, HYPERTENSION, V53, P993, DOI 10.1161/HYPERTENSIONAHA.109.130880
- Zoladz JA, 2010, J PHYSIOL PHARMACOL, V61, P533
- Sodersten K, 2014, J AFFECT DISORDERS, V160, P1, DOI 10.1016/j.jad.2014.01.009
- SULLIVAN MJ, 1989, CIRCULATION, V80, P769
- Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726
- EKLUND B, 1976, J PHYSIOL-LONDON, V262, P39
- BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020
- Forlenza OV, 2010, WORLD J BIOL PSYCHIA, V11, P774, DOI 10.3109/15622971003797241
- Trombetta IC, 2003, AM J PHYSIOL-HEART C, V285, pH974, DOI 10.1152/ajpheart.01090.2002
- Zoladz JA, 2008, J PHYSIOL PHARMACOL, V59, P119
- Fujimura H, 2002, THROMB HAEMOSTASIS, V87, P728
- Lin CY, 2013, INT J MOL SCI, V14, P15459, DOI 10.3390/ijms140815459
- Dietz NM, 1997, J PHYSIOL-LONDON, V498, P531
- Hariri AR, 2003, J NEUROSCI, V23, P6690
- Reed AS, 2000, J PHYSIOL-LONDON, V525, P253, DOI 10.1111/j.1469-7793.2000.t01-1-00253.x
- Negrao CE, 2001, AM J PHYSIOL-HEART C, V281, pH469
- MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
- Seifert T, 2010, AM J PHYSIOL-REG I, V298, pR372, DOI 10.1152/ajpregu.00525.2009
- Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024
- Hilberg T, 2003, EUR J APPL PHYSIOL, V90, P639, DOI 10.1007/s00421-003-0907-2
- Zoladz JA, 2014, J PHYSIOL PHARMACOL, V65, P441
- Huang T, 2014, SCAND J MED SCI SPOR, V24, P1, DOI 10.1111/sms.12069
- ZELIS R, 1974, CIRCULATION, V50, P137
- Pivac N, 2009, CROAT MED J, V50, P43, DOI 10.3325/cmj.2009.50.43
- Zoladz JA, 2010, PHARMACOL REP, V62, P494
- Negrao CE, 2000, AM J PHYSIOL-HEART C, V278, pH168
- Alves CR, 2013, PHYSIOL GENOMICS, V45, P487, DOI 10.1152/physiolgenomics.00065.2012
- Niebauer J, 1996, J AM COLL CARDIOL, V28, P1652
- Nakahashi T, 2000, FEBS LETT, V470, P113, DOI 10.1016/S0014-5793(00)01302-8
- Lin CY, 2014, BIOCHEM PHARMACOL, V91, P522, DOI 10.1016/j.bcp.2014.08.008
- Osanai T, 2000, AM J PHYSIOL-HEART C, V278, pH233
- Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004
- Gorman MW, 2012, EXERC SPORT SCI REV, V40, P37, DOI 10.1097/JES.0b013e3182348cdd
- Knaepen K, 2010, SPORTS MED, V40, P765, DOI 10.2165/11534530-000000000-00000
- Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7
- POHL U, 1986, HYPERTENSION, V8, P37
- Cheng AW, 2003, DEV BIOL, V258, P319, DOI 10.1016/S0012-1606(03)00120-9
- Nagappan G, 2009, P NATL ACAD SCI USA, V106, P1267, DOI 10.1073/pnas.0807322106
- Lung CC, 1997, J ALLERGY CLIN IMMUN, V99, P134, DOI 10.1016/S0091-6749(97)81054-8
- Usui T, 2014, ACTA PHYSIOL, V211, P385, DOI 10.1111/apha.12249
- Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034
- Hashimoto K, 2004, BRAIN RES REV, V45, P104, DOI 10.1016/j.brainresrev.2004.02.003
- CohenSolal A, 1995, PRESSE MED, V24, P1806
- Ribeiro F, 2013, AM J PHYS MED REHAB, V92, P1020, DOI 10.1097/PHM.0b013e31829b4c4f
- Shimizu E, 2004, AM J MED GENET B, V126B, P122, DOI 10.1002/ajmg.b.20118
- Chen Zhe-Yu, 2008, Novartis Found Symp, V289, P180
- Camm AJ, 1996, EUR HEART J, V17, P354
- Martins LB, 2015, NEUROSCI LETT, V587, P6, DOI 10.1016/j.neulet.2014.12.022
- Nascimento CMC, 2014, J ALZHEIMERS DIS, V43, P81
- Ribeiro F, 2009, INT J CARDIOL, V141, P214
- Souza C. A., 2000, CIRCULATION, V102, P1351
- Wasserman K, 1987, PRINCIPLES EXERCISE, P189
- WASSERMA.K, 1973, J APPL PHYSIOL, V35, P236
- Youn JY, 2009, CIRC RES, V104, P50, DOI 10.1161/CIRCRESAHA.108.178467